NAT10 and cancer: In cancer, inhibition of NAT10 is shown to increase DNA damage, decreased cell survival and cell cycle arrest; these properties could be explored to sensitize cancer cells to radiotherapy and chemotherapy by adding either of the screened drugs; Fosaprepitant, Leucal, Fludarabine and Dantrolene to the standard treatment regimen.